Bora Biologics Achieves 2,000L Scale-Up Milestone in US
San Diego, California, USA, April 6, 2026 Commercial-Scale Manufacturing Readiness Demonstrated In a significant advancement for biologics manufacturing and...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
San Diego, California, USA, April 6, 2026 Commercial-Scale Manufacturing Readiness Demonstrated In a significant advancement for biologics manufacturing and...
WALTHAM, Mass., USA — April 2, 2026 Thermo Fisher Scientific Inc. has announced the global launch of the Gibco™...
DALLAS, Texas — November 13, 2025: Burcon NutraScience Corporation reported significant progress in scaling and commercializing its next-generation plant-based...
Burlington, Massachusetts – October 15, 2025 – MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt,...
